A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis (original) (raw)
A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates
Charles-Antoine COUPET
PLOS ONE, 2015
View PDFchevron_right
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
Alberto Parra
Vaccine, 2013
View PDFchevron_right
Tuberculosis vaccines: Opportunities and challenges
Tom h.m. Ottenhoff
Respirology (Carlton, Vic.), 2018
View PDFchevron_right
Vaccines against Mycobacterium Tuberculosis: Exploring Alternate Strategies to Combat a Near-perfect Pathogen
Rasha Maal-Bared, Lionel G Filion
Mycobacterial Diseases, 2013
View PDFchevron_right
Vaccines against tuberculosis: moving forward with new concepts
Radha Gopal
Expert Review of Vaccines, 2013
View PDFchevron_right
A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis
Sylvie Bertholet
Science translational medicine, 2010
View PDFchevron_right
Development of novel carrier(s) mediated tuberculosis vaccine: More than a tour de force
ASHAY JAIN, Rajeev K Tyagi
European Journal of Pharmaceutical Sciences, 2014
View PDFchevron_right
Novel vaccine strategies against tuberculosis: a road less travelled
Supriya Pokkali
View PDFchevron_right
Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014
David Hokey
Vaccine, 2015
View PDFchevron_right
Recent progress in bacterial vaccines: Tuberculosis
Keith McAdam
International Journal of Infectious Diseases, 1997
View PDFchevron_right
Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis
Selvakumar Subbian
Biomedicines
View PDFchevron_right
“The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design” – Meeting report
Cesar Boggiano
Vaccine, 2017
View PDFchevron_right
An Overview of the Development of New Vaccines for Tuberculosis
AbuSalim Mustafa
Vaccines, 2020
View PDFchevron_right
Vaccines Against Tuberculosis: Problems and Prospects (Review)
Dmitry Karpov
2020
View PDFchevron_right
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
Satria Arief Prabowo, Ildikó Visontai, Traian Mihaescu
Medical microbiology …, 2012
View PDFchevron_right
Characterization of Novel Multiantigenic Vaccine Candidates with Pan-HLA Coverage against Mycobacterium tuberculosis
Lior Carmon, Galit Horn
Clinical and Vaccine Immunology, 2013
View PDFchevron_right
Novel tuberculosis vaccines on the horizon
Shreemanta Parida
Current Opinion in Immunology, 2010
View PDFchevron_right
Multi-Stage Tuberculosis Subunit Vaccine Candidate LT69 Provides High Protection against Mycobacterium tuberculosis Infection in Mice
Jianzhu Chen
PloS one, 2015
View PDFchevron_right
Mycobacterium tuberculosis & its recent vaccine approach: A review
Hamid Rehman
View PDFchevron_right
The Protective Effect of the Mycobacterium bovis BCG Vaccine Is Increased by Coadministration with the Mycobacterium tuberculosis 72-Kilodalton Fusion Polyprotein Mtb72F in M. tuberculosis-Infected Guinea Pigs
Yves Lobet
Infection and Immunity, 2004
View PDFchevron_right
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
joan joseph
Molecular Therapy - Methods & Clinical Development, 2019
View PDFchevron_right
A New Vaccine against Tuberculosis Affords Greater Survival after Challenge than the Current Vaccine in the Guinea Pig Model of Pulmonary Tuberculosis
g harth
Infection and Immunity, 2003
View PDFchevron_right
New strategies against an old plague: genetically engineered tuberculosis vaccines
Laurent Nicod
Schweizerische medizinische Wochenschrift
View PDFchevron_right
Translational Mini-Review Series on Vaccines:
Development and evaluation of improved vaccines against tuberculosis
Margherita Gigante
Clinical & Experimental Immunology, 2007
View PDFchevron_right
Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
Martin Rao
The Lancet Respiratory Medicine, 2014
View PDFchevron_right